WR Hambrecht Starts SHPGY at Buy; Sees BRL Settlement on Adderall XR
Tweet Send to a Friend
WR Hambrecht initiates coverage of Shire Pharmaceuticals Group (NASDAQ: SHPGY) with a 'Buy' rating and a $45 price target ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
